Market Tracker

10/24 6:02pm ET

Alexion Pharmaceuticals Inc (NASDAQ:ALXN)

190.29
Data as of Oct 24
 +4.37 / +2.35%
Today’s Change
113.14
Today|||52-Week Range
190.85
+43.20%
Year-to-Date

Today’s Trading

Previous close185.92
Today’s open185.50
Day’s range185.01 - 190.85
Volume1,812,764
Average volume (3 months)1,172,751
Market cap$37.6B
Dividend yield--
Data as of 3:59pm ET, 10/24/2014

Growth & Valuation

Earnings growth (last year)-0.78%
Earnings growth (this year)+67.82%
Earnings growth (next 5 years)+25.70%
Revenue growth (last year)+34.85%
P/E ratio96.1
Price/Sales17.19
Price/Book15.73

Competitors

 Today’s
change
Today’s
% change
SHPGShire PLC+9.51+5.14%
VRXValeant Pharmaceutic...+1.11+0.87%
VRTXVertex Pharmaceutica...+1.82+1.68%
PRGOPerrigo Company PLC+1.24+0.81%
Data as of 4:02pm ET, 10/24/2014

Financials

Last reporting dateOctober 23, 2014
EPS forecast (this quarter)$1.25
Annual revenue (last year)$1.5B
Annual profit (last year)$252.9M
Net profit margin16.73%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, CEO, Treasurer &
Director
Leonard Bell
Chief Operating Officer &
Director
David L. Hallal
Corporate headquarters
Cheshire, Connecticut

Forecasts